XTX Topco’s Clovis Oncology, Inc. CLVS Stock Holding History

XTX Topco’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-123,853	Closed	-$147K	–	1622
2022 Q3	$147K	Buy	123,853 +56,901	+85%	+$88.7K	0.04%	868
2022 Q2	$121K	Sell	66,952 -83,794	-56%	-$124K	0.05%	604
2022 Q1	$305K	Buy	150,746 +129,826	+621%	+$255K	0.13%	263
2021 Q4	$57K	Buy	+20,920	New	+$77.3K	0.03%	552

Other funds holding CLVS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CAS

Coppell Advisory Solutions Coppell, Texas $170M AUM 13.42% 1-Year Est. Return

CASC

Coppell Advisory Solutions Corp Coppell, Texas $531M AUM

STB

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

FFWM

Future Financial Wealth Management Cincinnati, Ohio $155M AUM 13% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

XTX Topco's CLVS Position: Q4 2022 in Review

XTX Topco sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 123,853 shares — an estimated $147K sold.

XTX Topco first reported a position in CLVS in Q4 2021 and held it in 4 quarters. The position peaked at $305K in Q1 2022. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

XTX Topco reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
XTX Topco sold 123,853 Clovis Oncology, Inc. shares in Q4 2022, an estimated $147K.
XTX Topco first reported a position in Clovis Oncology, Inc. in Q4 2021 and held it in 4 quarters.
XTX Topco's Clovis Oncology, Inc. position peaked at $305K in Q1 2022.
15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on XTX Topco's 13F filing for Q4 2022, filed 14 Feb 2023.